FAS and neoplasm: Our findings reported above, that 5-FU therapy upregulates Fas expression in MDSCs, to decrease MDSC accumulation in tumor-bearing mice, suggest that 5-FU therapy should also increase CTL activation, resulting in an increased level of tumor-infiltrating CTLs.